Autoantibodies to PAD4 and BRAF in rheumatoid arthritis

Autoimmunity Reviews
Isabelle AugerJean Roudier

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes cartilage and bone destruction. The mechanisms leading to RA are unknown. There is currently no reliable cure for RA. Early treatment can reduce inflammation, joint damage and bone destruction. Thus, early diagnosis of RA is critical. However, definitive diagnosis of RA can be difficult. Immunologic tests that can be performed for the diagnosis of RA include detection of anti citrullinated protein antibodies (ACPAs). However, one third of RA patients have no ACPAs. To identify new autoantibodies in RA, we used the sera of RA patients to screen protein arrays containing 8000 human proteins. We found and validated two major autoantigens: PAD4 (peptidyl arginine deiminase 4) and BRAF (v raf murine sarcoma viral oncogene homolog B1) catalytic domain. We identified peptide targets of anti PAD4 and BRAF autoantibodies. We observed that anti PAD4 are inhibitory whereas anti BRAF stimulate BRAF activity. Anti PAD4 and anti BRAF antibodies may be used to diagnose RA, particularly in the absence of anti citrullinated protein antibodies.

References

Dec 10, 1992·Nature·T M Roberts
Mar 1, 1992·International Journal of Radiation Biology·T M Koval, D L Suppes
Jun 1, 1995·Lupus·D P Symmons
Feb 14, 1998·The Journal of Clinical Investigation·G A SchellekensW J van Venrooij
Aug 4, 2004·Cancer Research·Mads Hald AndersenJürgen C Becker
Sep 14, 2004·BMC Cancer·Joachim FensterleUlf R Rapp
Apr 9, 2005·Rheumatology·S M J HarneyM A Brown
Feb 2, 2006·Rheumatology·T IwamotoN Kamatani
Sep 26, 2007·Annals of the New York Academy of Sciences·Akari SuzukiKazuhiko Yamamoto
Jan 12, 2008·Rheumatology·T ThalhamerM M Harnett
Feb 23, 2008·Annals of the Rheumatic Diseases·K NishimotoS Momohara
Jun 23, 2009·Autoimmunity Reviews·Consuelo AnzilottiPaola Migliorini
Oct 20, 2010·Arthritis Research & Therapy·Caroline CharpinIsabelle Auger

❮ Previous
Next ❯

Citations

Sep 29, 2012·Biochemistry Research International·Sunish MohananScott A Coonrod
Mar 21, 2013·Arthritis Research & Therapy·Steven G Gray
Mar 7, 2014·Clinical Reviews in Allergy & Immunology·Qianjin Lu
Jul 16, 2015·Journal of Pharmaceutical and Biomedical Analysis·Min ParkMin-Jung Kang
Apr 20, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Magda LourdaMattias Svensson
Jan 24, 2018·American Journal of Physiology. Renal Physiology·Hongmei LiH Thomas Lee
May 1, 2018·Clinical Chemistry and Laboratory Medicine : CCLM·Pier Luigi Meroni, Maria Orietta Borghi
Apr 4, 2019·American Journal of Physiology. Renal Physiology·May M RabadiH Thomas Lee
Jan 19, 2019·Advances in Rheumatology·Sara de Brito RochaLuis Eduardo Coelho Andrade
May 14, 2020·Journal of Medical Economics·Maurizio BenucciMariangela Manfredi
Sep 24, 2020·International Journal of Rheumatic Diseases·Jie LiJin-Qi Li
Jun 13, 2018·Frontiers in Immunology·V Michael Holers, Nirmal K Banda
May 4, 2013·Chembiochem : a European Journal of Chemical Biology·Erin Wildeman, Marcos M Pires
Feb 4, 2021·International Journal of Molecular Sciences·Maria Sofia BasileEugenio Cavalli
Feb 26, 2021·Therapeutic Advances in Musculoskeletal Disease·Bogdan KolarzMaria Majdan
Mar 23, 2021·Autoimmunity Reviews·Nora PetrovskáMária Filková

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.